Argenx Se (ARGX) Property, Plant & Equipment (Net) Growth (1y) (2016 - 2026)
Argenx Se (ARGX) Property, Plant & Equipment (Net) Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 58.66% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -10.19% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 2.65% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 24.11% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 12.18% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | -95.71% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 37.29 Bn | 34.28 Bn | 959.66 Mn | 3.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -95.71% |
| Dec 31, 2025 | 35.21% |
| Jun 30, 2025 | 123,901.52% |
| Dec 31, 2024 | 215.11% |
| Jun 30, 2024 | 151.64% |
| Dec 31, 2023 | 1,121.40% |
| Jun 30, 2023 | 3.03% |
| Dec 31, 2022 | -88.84% |
| Jun 30, 2022 | 25.01% |
| Dec 31, 2021 | 48.88% |
| Jun 30, 2021 | 13.77% |
| Dec 31, 2020 | 201.70% |
| Jun 30, 2020 | 49.50% |
| Dec 31, 2019 | 899.50% |
| Jun 30, 2019 | 517.26% |
| Dec 31, 2018 | 98.52% |
| Jun 30, 2018 | -14.74% |
| Dec 31, 2017 | 211.88% |
| Dec 31, 2016 | 207.63% |